175 related articles for article (PubMed ID: 33453311)
1. Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?
Imam I; Hammarström K; Sjöblom T; Glimelius B
Radiother Oncol; 2021 Apr; 157():70-77. PubMed ID: 33453311
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.
Huang WS; Kuan FC; Lin MH; Chen MF; Chen WC
Ann Surg Oncol; 2020 Oct; 27(11):4309-4318. PubMed ID: 32794029
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
[TBL] [Abstract][Full Text] [Related]
6. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
7. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
[TBL] [Abstract][Full Text] [Related]
8. The neoadjuvant rectal score and a novel magnetic resonance imaging based neoadjuvant rectal score are stage independent predictors of long-term outcome in locally advanced rectal cancer.
McMahon RK; O'Cathail SM; Nair H; Steele CW; Platt JJ; Digby M; McDonald AC; Horgan PG; Roxburgh CSD
Colorectal Dis; 2023 Sep; 25(9):1783-1794. PubMed ID: 37485654
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study.
Couwenberg AM; Burbach JPM; Intven MPW; Consten ECJ; Schiphorst AHW; Smits AB; Wijffels NAT; Heikens JT; Koopman M; van Grevenstein WMU; Verkooijen HM
Acta Oncol; 2019 Apr; 58(4):407-416. PubMed ID: 30656996
[TBL] [Abstract][Full Text] [Related]
10. Disqualification of Neoadjuvant Rectal Score Based on Data of 6596 Patients From the Netherlands Cancer Registry.
van der Valk MJM; Vuijk FA; Putter H; van de Velde CJH; Beets GL; Hilling DE
Clin Colorectal Cancer; 2019 Jun; 18(2):e231-e236. PubMed ID: 30772135
[TBL] [Abstract][Full Text] [Related]
11. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial.
Kairevičė L; Latkauskas T; Tamelis A; Petrauskas A; Paužas H; Žvirblis T; Jaruševičius L; Saladžinskas Ž; Pavalkis D; Jančiauskienė R
Medicina (Kaunas); 2017; 53(3):150-158. PubMed ID: 28690144
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer.
Shah S; Asawa P; Abel S; Wegner RE
J Gastrointest Cancer; 2023 Sep; 54(3):829-836. PubMed ID: 36253514
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
14. Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
Zhang YX; Liu HY; Jiang B; Wang WY; Wang HB; Lu YJ
Eur J Surg Oncol; 2020 Mar; 46(3):410-414. PubMed ID: 31627933
[TBL] [Abstract][Full Text] [Related]
15. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
16. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial.
Latkauskas T; Pauzas H; Kairevice L; Petrauskas A; Saladzinskas Z; Janciauskiene R; Gudaityte J; Lizdenis P; Svagzdys S; Tamelis A; Pavalkis D
BMC Cancer; 2016 Dec; 16(1):927. PubMed ID: 27903247
[TBL] [Abstract][Full Text] [Related]
17. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant rectal score is prognostic for survival: A population-based propensity-matched analysis.
Naffouje SA; Manguso N; Imanirad I; Sahin IH; Xie H; Hoffe S; Frakes J; Sanchez J; Dessureault S; Felder S
J Surg Oncol; 2022 Dec; 126(7):1219-1231. PubMed ID: 35916542
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial.
Fokas E; Fietkau R; Hartmann A; Hohenberger W; Grützmann R; Ghadimi M; Liersch T; Ströbel P; Grabenbauer GG; Graeven U; Hofheinz RD; Köhne CH; Wittekind C; Sauer R; Kaufmann M; Hothorn T; Rödel C;
Ann Oncol; 2018 Jul; 29(7):1521-1527. PubMed ID: 29718095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
